Similarly, ATX-101 demonstrates the capacity of CPPs to enhance the efficacy of DNA-damaging agents by disrupting PCNA, a critical protein involved in DNA repair and cell survival, thus sensitizing cancer cells to chemotherapy. This evidence concerns the gene PCNA and cancer.